(Q37727991)

22 August 2017

1 reference

title

Thymoma and paraneoplastic myasthenia gravis (English)

1 reference

22 August 2017

0 references

A Marx

1

1 reference

22 August 2017

N Willcox

2

1 reference

22 August 2017

M I Leite

3

1 reference

22 August 2017

W-Y Chuang

4

1 reference

22 August 2017

B Schalke

5

1 reference

22 August 2017

W Nix

6

1 reference

22 August 2017

P Ströbel

7

1 reference

22 August 2017

1 August 2010

1 reference

22 August 2017

1 reference

22 August 2017

43

1 reference

22 August 2017

413-427

1 reference

22 August 2017

5-6

1 reference

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response

22 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

The auto-antigen repertoire in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Projection of an immunological self shadow within the thymus by the aire protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Pathology of thymic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Clonal analysis reveals a common progenitor for thymic cortical and medullary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Formation of a functional thymus initiated by a postnatal epithelial progenitor cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Thymus medulla consisting of epithelial islets each derived from a single progenitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Follow-up study of thymomas with special reference to their clinical stages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Association of HLA-A in autoimmune myasthenia gravis with thymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

An institutional study on thymomas and thymic carcinomas: experience in 77 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Evaluation of a histogenetic classification for thymic epithelial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Recurrent genetic aberrations in thymoma and thymic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Thymomas express epitopes shared by the ryanodine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Scenarios for autoimmunization of T and B cells in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Absence of acetylcholine-induced current in epithelial cells from thymus glands and thymomas of myasthenia gravis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Paraneoplastic myasthenia gravis: immunological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Clinical spectrum of voltage-gated potassium channel autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Autoimmunizing mechanisms in thymoma and thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Early stages in the development of human T, natural killer and thymic dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Untangling the T branch of the hematopoiesis tree

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Pathogenesis of Myositis and Myasthenia Associated with Titin and Ryanodine Receptor Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

CD45 isoform expression in autoimmune myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Transplantation tolerance induced in foetal mouse thymus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

The cellular mechanism of Aire control of T cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Genetic factors in autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Pathogenesis of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Correlation of thymic pathology with HLA in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Myasthenia gravis seronegative for acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Clinical and pathological aspects of thymic epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Thymoma: a focus on current therapeutic management.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Clinical management of thymoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

21 January 2018

Management of thymomas

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Systemic treatment of malignant thymoma: a decade experience at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Antibodies to thymic epithelial cells in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

A CTLA4high genotype is associated with myasthenia gravis in thymoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

AIRE deficiency in thymus of 2 patients with Omenn syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

Changes in thymic function with age and during the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903555935

10.3109/08916930903555935

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference